Spondyloepimetaphyseal dysplasia with elevated plasma lysosomal enzymes caused by homozygous variant in MBTPS1

Am J Med Genet A. 2020 Jul;182(7):1796-1800. doi: 10.1002/ajmg.a.61614. Epub 2020 May 18.

Abstract

Variants in MBTPS1 (membrane-bound transcription factor peptidase, site 1) encoding the protein convertase site-1 protease (S1P) were recently reported in a single individual with skeletal dysplasia and elevated plasma lysosomal enzymes. Here, we report the second individual with this newly described autosomal recessive spondyloepiphyseal dysplasia (OMIM #618392), presenting severe growth retardation, cataract and dysmorphic features, mainly retromicrognathia. Epilepsy and craniosynostosis were novel findings in our proband. She was found to be homozygous for a novel nonsense variant p.Trp983Ter in MBTPS1. In addition, she had normal levels of lysosomal enzyme activity in leukocytes but elevated levels in plasma. Our description confirms the existence of this new skeletal dysplasia and expands the phenotype and genotype of the disease.

Keywords: MBTPS1; cataract; retromicrognathia; site-1 protease (S1P); spondylepimetaphyseal dysplasia.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cataract / diagnostic imaging
  • Cataract / genetics*
  • Cataract / pathology
  • Child, Preschool
  • Female
  • Humans
  • Lysosomal Storage Diseases / blood
  • Lysosomal Storage Diseases / diagnostic imaging
  • Lysosomal Storage Diseases / genetics*
  • Lysosomal Storage Diseases / pathology
  • Lysosomes / enzymology
  • Lysosomes / genetics*
  • Pedigree
  • Phenotype
  • Proprotein Convertases / genetics*
  • Serine Endopeptidases / genetics*

Substances

  • Proprotein Convertases
  • Serine Endopeptidases
  • membrane-bound transcription factor peptidase, site 1